CD133 Antibody MAB11331-100 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemCD133 Antibody
CompanyR&D Systems, a Bio-Techne Brand
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberMAB11331-100
Quantity100 ug (also 25 ug)
ApplicationsFlow Cytometry, CyTOF-ready
Conjugate/TagUnconjugated
ReactivityHuman
TargetCD133
IsotypeIgG2a
Clone170411
HostMouse
ImmunogenNS0 mouse myeloma cell line transfected with human CD133, Accession # O43490
Brand/TrademarkR&D Systems, a Bio-Techne Brand
NCBI Full Gene Nameprominin 1
NCBI Gene AliasesCORD12, CD133, RP41, MCDR2, STGD4, AC133, MSTP061, PROML1
ClonalityMonoclonal
PurityProtein A or G purified from hybridoma culture supernatant
FormatLyophilized from a 0.2 µm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS
Antibody TypePrimary Antibodies
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution

Available conjugates: Unconjugated

Specificity: Detects human CD133

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

(1) Altered Functionality of Lipoprotein(a) Impacts on Angiogenesis in Diabetic RetinopathyInvestigative ophthalmology & visual scienceMay 1, 2023Shariatzadeh M, Nagtzaam NMA, van Vark-van der Zee L, van Holten-Neelen C, Verhoeven AJM, Dehairs J, Swinnen JV, Leijten F, Ten Berge JC, Ciriano JPM, et al.

(2) Multipurpose E-bioplatform targeting Kv channels in whole cancer cells and evaluating of their potential therapeuticsAnalytica chimica actaOctober 23, 2022Zouari M, Aissaoui-Zid D, Campuzano S, Barderas R, Srairi-Abid N, Pingarrón JM, Raouafi N.

(3) Clinical impact of different exosomes' protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapyPloS oneJanuary 1, 2019Giampieri R, Piva F, Occhipinti G, Bittoni A, Righetti A, Pagliaretta S, Murrone A, Bianchi F, Amantini C, Giulietti M, et al.

(4) Musashi-1 promotes a cancer stem cell lineage and chemoresistance in colorectal cancer cellsScientific reportsMay 19, 2017Chiou GY, Yang TW, Huang CC, Tang CY, Yen JY, Tsai MC, Chen HY, Fadhilah N, Lin CC, Jong YJ.

CD133 Antibody